Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026)

Zymeworks (ZYME) reported Other Non-Current Liabilities of $278000.0 for Q1 2026, down 67.52% on a YoY basis from $856000.0 in Q1 2025, and little changed sequentially from $278000.0 in Q4 2025.

Zymeworks (ZYME) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of Other Non-Current Liabilities data on file, last reported at $278000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Liabilities fell 67.52% year-over-year to $278000.0; the trailing twelve-month figure through Mar 2026 stood at $278000.0 (down 67.52% YoY), and the FY2025 full-year result was $278000.0, down 69.88% from the prior year.
  • Other Non-Current Liabilities held at $278000.0 in Q1 2026, from $278000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $3.6 million in Q2 2023 to a low of $278000.0 in Q3 2025.
  • A 5-year average of $1.4 million and a median of $929000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • Across the five-year window, Other Non-Current Liabilities tumbled 90.01% in 2023 and surged 217.06% in 2024, its largest moves.
  • Tracing ZYME's Other Non-Current Liabilities over 5 years: stood at $1.6 million in 2022, then climbed by 3.59% to $1.7 million in 2023, then sank by 45.74% to $923000.0 in 2024, then slumped by 69.88% to $278000.0 in 2025, then changed by 0.0% to $278000.0 in 2026.
  • Business Quant data shows ZYME's Other Non-Current Liabilities at $278000.0 in Q1 2026, $278000.0 in Q4 2025, and $278000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Zymeworks 1.70 Bn 1.34 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 278,000.00
Dec 31, 2025 278,000.00
Sep 30, 2025 278,000.00
Jun 30, 2025 828,000.00
Mar 31, 2025 856,000.00
Dec 31, 2024 923,000.00
Sep 30, 2024 929,000.00
Jun 30, 2024 1.23 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 1.70 Mn
Sep 30, 2023 293,000.00
Jun 30, 2023 3.60 Mn
Mar 31, 2023 3.60 Mn
Dec 31, 2022 1.64 Mn
Sep 30, 2022 2.93 Mn
Dec 31, 2021 2.75 Mn